Sox2 is a transcriptional regulator that is highly expressed in retinal astrocytes, yet its function in these cells has not previously been examined. To understand its role, we conditionally deleted
| I N TR ODU C TI ON
Astrocytes play many roles in the developing and mature central nervous system (CNS), including the retina. They promote growth and maturation of neuronal cells by stimulating synaptogenesis and axon growth (Allen et al., 2012; Barker & Ullian, 2008; Christopherson et al., 2005; Ullian, Sapperstein, Christopherson, & Barres, 2001 ), secrete growth factors necessary for neuronal differentiation and survival (Banker, 1980; Liesi & Silver, 1988) , aid in synaptic pruning (Stevens et al., 2007) , and buffer ions in the extracellular space (Newman, 1986) .
Within the retina, the stellate morphology of the astrocytes forms a web-like network of overlapping processes that use gap-junctions to propagate intracellular signals and establish metabolic homeostasis (Hollander et al., 1991; Ramirez, Trivino, Ramirez, Salazar, & GarciaSanchez, 1996) . Astrocytes also play an important role in the vascularization of the retina (Dorrell et al., 2010; Dorrell, Aguilar, & Friedlander, 2002; O'Sullivan et al., 2017) , providing a scaffold for blood vessels to follow as they migrate from the optic nerve head (ONH) across the inner surface of the retina via the secretion of growth factors such as vascular endothelial growth factor (VEGF).
Astrocytes constitute the majority of cells in the CNS (Molofsky et al., 2012 ), yet surprisingly little is known about the genetic factors that regulate their development. Transcriptome analysis performed on purified populations of astrocytes derived from mouse cortical tissue found Sox2 to be within the top 10% of all expressed genes (Cahoy et al., 2008) . In addition, Sox2 expression is enriched in astrocytes, being expressed at higher levels than in cortical neurons and other glial cells (Cahoy et al., 2008; Zhang et al., 2014) . In the retina, Sox2 is only expressed within three cellular populations, cholinergic amacrine cells, M€ uller glia, and astrocytes, being the most abundant within the astrocytic population (Macosko et al., 2015; Whitney et al., 2014) . Sox2 belongs to the large SRY-related HMG-box transcription factor family and is best recognized for its role in early development by maintaining embryonic stem cell pluripotency (Matsushima, Heavner, & Pevny, 2011; Taranova et al., 2006) . Sox2 is also a critical gene for eye development as mutations in humans lead to severe abnormalities in eye formation (Fantes et al., 2003; Schneider, Bardakjian, Reis, Tyler, & Semina, 2009 ). In addition, it has been suggested that Sox2 is able to promote glial cell survival in cultures of dorsal root ganglion cells (Koike, Wakabayashi, Mori, Hirahara, & Yamada, 2015) . Given these documented roles for Sox2, the present study has assessed its role in the development of retinal astrocytes.
Using a conditional deletion strategy to excise Sox2 from the population of retinal astrocytes, we examined the consequences for astrocytic and vascular development, and for the astrocytic and vascular architecture in maturity. While we found no alteration in the spatio-temporal time-course of astrocyte migration across the retina, we observed a conspicuously delayed expression of glial fibrillary acidic protein (GFAP), a hallmark of their maturation. Vascular invasion across the retinal surface was also delayed. In maturity, the adult retina exhibited an aberrant distribution of astrocytic processes as well as vascular network abnormalities, yet the overall architecture of the retina was unaffected. These data identify Sox2 as an important participant in the development of astrocytes, and suggest a complex interaction with the forming vasculature in the mouse retina. Figure S1 ). All GFAP-Cre control animals (CTL) were CKO littermates that lacked GFAP-Cre and/or Sox2-loxP alleles. All three lines of mice were obtained from The Jackson Laboratories (Bar Harbor, MA; GFAP-Cre: #004600; Sox2-flox: #013093; Rosa-EYFP: #006148). Retinas were examined from postnatal mice, and into maturity, with retinas older than 21 days of age designated as adult 
| Tissue preparation
Mice were given a lethal injection of sodium pentobarbital (120 mg/kg, i.p.) and, once deeply anesthetized, were intracardially perfused with 2 ml of saline followed by 50 ml of 4% paraformaldehyde dissolved in sodium phosphate buffer (pH 7.2, at 208C). Whole retinas were subsequently dissected from eyes and processed for wholemount preparations or cut into 150 mm on a Vibratome. Particular care was taken to prevent damage to the inner surface of the retina during dissection.
| Immunostaining
Dissected wholemount retinas or sections were incubated in 5% normal donkey serum in phosphate-buffered saline (PBS) with 1% Triton-X for three hours. They were then rinsed in PBS and incubated in primary antibodies diluted in PBS with 1% Triton-X for 72 hrs. Primary antibodies used in this study are listed in Table 1 . In addition, Hoechst (Invitrogen, Eugene, OR; 1:1,000), NeuroTrace 530/615 (ThermoFisher Scientific, Waltham, MA; #N21482, 1:500) and/or PNA lectin conjugated to Alexa Fluor 647 (ThermoFisher Scientific, Waltham, MA; #L32460, 1:500) were used and added to the solution of primary antibodies. Retinas were subsequently rinsed in PBS and incubated overnight in the secondary antibodies. All secondary antibodies were raised in donkey and conjugated to AlexaFluor dyes (Jackson ImmunoResearch Laboratories, West Grove, PA; 1:200). All steps were conducted under agitation at 48C.
| Image acquisition
Adult wholemount retinal images were assembled from 250 403 maximum projection fields stitched together using Imago 1.5 (Mayachitra Inc., Santa Barbara, CA) to create a single high-resolution image of the entire retina. Postnatal retinal images were comprised of 18 103 maximum projection fields similarly stitched together. Each projection was taken from 40 optical sections at 1 mm intervals through the zaxis. For the analysis of astrocytic sprouting, large fields (0.81 mm 2 ) were made by stitching 16 individual 403 z-stacks at 4 different locations on the retina, one per quadrant. All images were acquired on an Olympus FV1000 scanning laser confocal microscope. The 12 measurements were averaged to yield values for each retina, and a two-tailed student's t-test was performed, using a threshold for statistical significance of p .05.
All quantification was conducted without knowledge of genotype, with either the retinas or confocal micrographs being coded and randomly intermingled beforehand.
| RE S U L TS

| Characterization of the Sox2-CKO retina
The conditional deletion of Sox2 from retinal astrocytes was confirmed in the mature retina by the absence of Sox2 immunoreactivity from all Figure S2 ).
| Sox2-deficient astrocytes exhibit a delayed maturation
We first investigated whether the loss of Sox2 in astrocytes causes a disruption to their development. Immature astrocytes expressing Sox2 migrate into the retina from the ONH shortly before the day of birth, by responding to environmental cues such as platelet-derived growth factor A-chain (PDGF-A) (Fruttiger et al., 1996) , laminins ß2 and g3 (Gnanaguru et al., 2013) , and the axons of retinal ganglion cells (Distler, Dreher, & Stone, 1991; O'Sullivan et al., 2017) . These immature astrocytes, visualized by expression of Pax2, migrate radially across the retinal surface, reaching the peripheral edge of the retina by postnatal (P) day 5 (Chu, Hughes, & Chan-Ling, 2001; Chan-Ling, Chu, Baxter, Weible, & Hughes, 2009; Ling, Mitrofanis, & Stone, 1989; Sandercoe, Madigan, Billson, Penfold, & Provis, 1999; Stone & Dreher, 1987; Watanabe & Raff, 1988) . At P1, migrating Pax2-positive astrocytes are found in both CTL and CKO retinas with no apparent differences in their spatial distribution nor in their morphologies ( Astrocytes express GFAP at low levels during the perinatal period as they invade the retina (West, Richardson, & Fruttiger, 2005) , but gradually increase expression throughout postnatal development until expression plateaus around P10 (Sarthy, Fu, & Huang, 1991; Tao & Zhang, 2014) , when Pax2 labeling of astrocytes gradually subsides. CKO astrocytes also exhibit a delayed GFAP upregulation peripherally (e,f,j, CTL: n 5 4, CKO: n 5 4). At P10, GFAP-positive astrocyte processes (g, arrowheads) nearly reach the far peripheral margin of the retina (g, dashed line). Processes closer to the central retina become thinner and begin forming the web-like morphology characteristic of GFAP-positive processes seen in mature CTL retinas (g). In P10 CKO retinas however, the extension of GFAP-positive processes (h, arrowheads) is significantly delayed, usually failing to reach the retinal margin (h, red dashed line) by this age (j, CTL: n 5 4, CKO: n 5 5). In addition, GFAP-positive processes at more central locations show a delay in their acquisition of the more mature patterning exhibited in CTL retinas (h). Cross in j represents an outlier not included in the statistical analysis. Scale bar 5 500 mm. * 5 p .05 [Color figure can be viewed at wileyonlinelibrary.com] (Figure 3g ), while this is notably delayed in the CKO retinas. GFAPprocesses in the P10 CKO retinas exhibit a morphology that outlines the emerging vasculature, existing as thicker bundles of processes, not unlike that in the central retina in P5 CTLs (Figure 3b,h ). Taken together, the data from these developmental time-points indicate that Sox2 plays a key role in the maturation of astrocytes in the developing retina.
| Adult astrocytes exhibit morphological abnormalities
To assess whether these developmental abnormalities might translate into lasting changes within the population of mature astrocytes, we Figure S3 ). However, some quadrants remain unaltered, indicating that astrocytes are capable of migrating to the retinal margin in CKO animals. That they had done so, earlier in development in these affected quadrants, is supported by the observation that the retinal vasculature is present in these depleted regions (Supporting Information Figure S3d , d 0 ). These results suggest that the depleted territory reflects a regressive event but whether it is due to an abnormal loss of GFAP immunoreactivity or apoptosis of the astrocytes themselves, is unclear.
The processes of wildtype astrocytes, labeled with GFAP, are normally restricted to the retinal NFL, with little to no labeling extending into the inner retina (Figure 5a-d) . In injury conditions however, like that of retinal detachment, mouse astrocytes have been shown to extend processes into the inner retina (Luna et al., 2016) . In regions of the CKO retina removed from the astrocytic deficit, we observed aberrant astrocytic sprouting into the inner plexiform layer (IPL), well beyond the normal stratified distribution within the NFL (Figure 5e -h).
These retinas exhibit, on average, an eight-fold increase in the density of processes extending into the IPL compared to controls, albeit CKO samples showed conspicuous variability (Figure 5i , p 5 .012). These sprouted processes in CKO retinas can extend over a hundred microns into the retina and appear to stratify at particular depths as seen in high magnification z-stack reconstructions from 120 mm thick stacks from CTL and CKO retinas (Figure 5j ,k; Supporting Information Videos S1 and S2). These processes are invariably traced to astrocytes in the inner retina, and are not associated with the M€ uller glia. Indeed, sectioned retinas show the Vimentin-positive architecture to be unchanged in the CKO retinas (Supporting Information Figure S4a 
| CKO retinas exhibit delays in vascular growth
It is known that as astrocytes enter the retina, they secrete many factors, including VEGF, which serve as migratory guides for endothelial tip cells residing on the leading edge of the developing retinal vasculature (Fruttiger, 2002; Jiang, Bezhadian, & Caldwell, 1995; Zhang et al., 2014) . The apparent delay in astrocyte maturation suggested a potential effect upon the maturation of the vasculature itself. Indeed, the normal invasion of the vasculature, from the ONH to the retinal periphery, was conspicuously delayed compared to that of controls, as evidenced by the pattern of Collagen IV immunostaining in whole retinas (Figure 6a-g ). At P5, the developing retinal vasculature in CTL retinas extends from the ONH to roughly 55% of the distance to the peripheral margin. In the more central regions, this web of maturing vessels contours nicely with the ring-like pattern of astrocytes at this same age (compare with Figure 3c ). By contrast, the developing retinal vasculature is delayed in the CKO retinas, having extended only 33% of this centro-peripheral dimension (Figure 6a Given the sprouting observed in the population of mature astrocytes in CKO retinas, we examined other features of the mature vascular network in further detail. But with one exception (Supporting Information Figure S5g ), the CKO vasculature showed no gross morphological differences from control animals, aside from the abovementioned absence at the extreme margin of the retina (Figure 6c,f,g ); detailed analysis, however, revealed subtle changes to the vascular architecture, pervasive throughout the retina (Figure 6h 
| D ISC USSION
Here, we identify a novel role for the transcription factor Sox2 in the development of retinal astrocytes and vasculature. We show that Sox2 is necessary for the time course of astrocytic maturation in early postnatal development, as well as for the establishment and/or maintenance of astrocytic morphology in adulthood, evidenced by the regional loss of GFAP expression and aberrant sprouting into the inner retina after its removal. Vascular invasion into the retina in these CKO animals is also delayed and defects to the vascular network are present in adulthood.
To our knowledge this is the first evidence that Sox2 plays a role than it does during early embryonic development, notably by influencing cellular maturation and morphology.
| Sox2 is required for astrocytic maturation
Sox2 is a highly conserved transcriptional regulator of stem cell pluripotency, and is well known to play an essential role in all stages of CNS development in mammals (Kiefer, 2007) . As astrocyte precursor cells mature, they downregulate genes such as Pax2 and Vimentin while concurrently upregulating GFAP and S100b, among others (reviewed in Tao & Zhang, 2014) . While it is known that Sox2 is present in astrocyte precursor cells and in mature astrocytes, how it interacts with other genes, in cells other than neural stem cells, remains to be determined.
Our data implicate Sox2 as essential for astrocytic maturation as evidenced by the delayed upregulation of GFAP when Sox2 is genetically removed from developing astrocytes.
We confirmed that Sox2 was removed from astrocytes by the day of birth, and while Cre-mediated excision of Sox2 occurred prior to the normal upregulation of GFAP, we suspect this could be due to differential regulation of the GFAP-Cre transgene compared to the endogenous GFAP promoter. Cre expression appears to be consistent with the endogenous localization of GFAP, however, since almost all Crepositive cells in the NFL of the adult retina were determined to be astrocytes, and almost all astrocytes were determined to be Crepositive (Supporting Information Figure S1 ). Furthermore, these astrocytes were shown to be Sox2-negative in CKO retinas, while the population of cholinergic amacrine cells remained Sox2-positive (Figures 1   and 2 ).
Sox2 likely plays a role in cellular maintenance, given the observed regional loss of astrocytes and their atypical sprouted morphology in the mature retina. Sox2 is traditionally regarded as a transcriptional activator, although more recent studies have suggested that Sox2 can function as a repressor in neural stems cells (Liu et al., 2014) . Indeed, Sox2 has been reported to repress the GFAP promoter in vitro, although it is known that genes can act as both activators and repressors depending on the tissue and cell type they are expressed in, as well as the availability of cofactors (Liu et al., 2014) . Those studies would suggest that GFAP may be an activational target of Sox2, either directly, or indirectly. That GFAP is eventually upregulated shows that other factors must participate; despite this, the lasting changes make clear the critical role for Sox2 expression at a particular developmental stage for normal astrocytic maturation.
| Sox2 removal from astrocytes delays retinal vascularization
It has been postulated that astrocyte maturation, indexed by GFAP upregulation, could result from the heightened availability of oxygen following angiogenesis (West et al., 2005; Zhang, Porat, Alon, Keshet, & Stone, 1999) . In the present study, we observed a delay in vascularization following the removal of Sox2 from astrocytes. Given that vessels spread radially across the retinal surface following factors produced by astrocytes, a likely hypothesis is that Sox2-deficient astrocytes may alter this process leading to abnormal angiogenesis.
Developing astrocytes are known to secrete VEGF (Chan- West et al., 2005) in response to the hypoxic conditions present before tissue vascularization has taken place (Provis et al., 1997; West et al., 2005) . Endothelial tip cells, at the leading edge of the developing vascular network, express the VEGF receptor VEGFR2 (Gerhardt et al., 2003) . Their activation by VEGF has been shown to promote their extension towards the retinal periphery (Dorrell et al., 2002; Gerhardt et al., 2003; Ruhrberg et al., 2002; Stone et al., 1995; West et al., 2005) . This arrival of blood vessels brings oxygen and therefore reduces the anoxic state. As it has been proposed that the availability of oxygen itself may trigger the maturation of the astrocytes (including the upregulation of GFAP) (West et al., 2005; Zhang et al., 1999) , the present results suggest that the role of Sox2 is a complex expression by endothelial cells is believed to inhibit astrocytic VEGF expression and promote GFAP activation, thereby promoting maturation of astrocytes (Kubota & Suda, 2009; Kubota, Hirashima, Kishi, Stewart, & Suda, 2008; Mi, Haeberle, & Barres, 2001; Nakashima, Yanagisawa, Arakawa, & Taga, 1999) . The astrocytic deletion of Sox2 could cause a delayed maturation by indirectly decreasing LIF production, for example, to further impede astrocytic maturation.
| Astrocytic and vascular aberrations in the mature retina
While there is strong evidence for the interaction between astrocytes and blood vessels in development as previously described, less is known about their relationship in mature animals. In this study we have not only uncovered a role for Sox2 in the developing retina but observe permanent aberrations to the astrocytic and vasculature networks in the mature retina as well. CKO retinas show a regional loss of GFAP immunoreactivity at peripheral locations, yet this has never been observed at central eccentricities near the ONH. Curiously, this regional difference is only observed for this specific phenotype; the
astrocytic sprouting, as well as changes to the vasculature, occur at all locations across the retinal surface.
Given our observation that angiogenesis is delayed in CKO animals, this suggests that the peripheral retina may experience a prolonged period of anoxia, in turn further impacting the maturation of the astrocytes, perhaps by the diminished availability of other factors.
While speculative, it appears plausible given the sustained interaction, both physical and metabolic, between astrocytes and blood vessels in the mature animal (reviewed in Sofroniew & Vinters, 2010) .
We first observe the peripheral loss of GFAP labeling around P15, yet it appears in all CKO animals by P21. The extent of these depleted regions is not age-dependent; older animals do not exhibit more quadrants or larger peripheral patches with GFAP loss. This implies that the diminution of GFAP in the peripheral retina is not a severe degenerative phenotype but instead a consequence of an earlier developmental deficit. Immunostaining for an alternative astrocytic marker, Sox9, yields no evidence for astrocytes remaining within GFAP-deficient peripheral patches (Supporting Information Figure S7 ). While this result might suggest that astrocytes have undergone apoptosis in these regions, it is conceivable that they have simply lost these differentiated features of astrocytes, and are therefore unrecognizable when labeling for GFAP or Sox9. This is not so implausible when considering the loss of cellular identity when Sox2 is removed from cholinergic amacrine cells in the retina; while these cells retain their cholinergic status, they lose other features that discriminate between the ON versus OFF populations, including the loss of monostratified dendritic arbors in the ON population, and the loss P2X2 receptor labeling in the OFF population (Whitney et al., 2014) .
What remains to be elucidated is how the aberrant astrocytic sprouting relates to our other described adult phenotype, namely that of the peripheral GFAP loss. It has been previously reported that in mouse models of retinal detachment, astrocytes not only sprout into the neural retina but also upregulate GFAP (Luna et al., 2016) . In this injury condition, remodeled astrocytic processes follow blood vessels into the inner retina, yet in our CKO retinas we have not observed any obvious correlation. In addition, we do not observe any upregulation of GFAP, rather the opposite, implying that different processes control the two astrocytic phenotypes we describe. Conversely, the loss of Sox2 could create an intrinsic level of cellular stress thereby causing some astrocytes to undergo apoptosis, perhaps in regions providing less trophic support, while causing others to remodel by aberrantly extending their processes.
We observed a less complex superficial blood vessel network in CKO retinas, by measures of branch point frequency and vessel length.
We believe this to be a lasting result of the delay in angiogenesis, yet it could be due to a remodeling of the network after reaching the retinal margin. Other groups have argued that if vascular branch points are decreased then overall vessel length should increase conversely (Giocanti-Auregan et al., 2016 ), yet we observe a significant decrease in both. This indicates a general underdevelopment of the vascular network. In severely astrocyte-depleted patches we have observed substantial aberrations to blood vessel patterning, i.e. the appearance of tortuous thickened vessels lacking finer capillary networks (Supporting Information Figure S3g ). Most CKO retinas did not exhibit conspicuous abnormalities such as this, yet all showed an overall diminution of the superficial vascular plexus (Figure 6f ,j,k). Taken together these data implicate Sox2 as an important if indirect player in the development of the vascular network, mediated by the retinal astrocytes.
